Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Civik Thomas Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 Civik Thomas (Director) has filed a Form 4 on Repare Therapeutics Inc.
Txns: Granted 27,200 options to buy @ $11.66, valued at $317.2k
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.
Txns: Granted 66,831 shares @ $0
11/19/2021 4 Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.
Txns: Bought 15,700 shares @ $12.74, valued at $200k
11/18/2021 4 Civik Thomas (Director) has filed a Form 4 on Repare Therapeutics Inc.
Txns: Bought 7,500 shares @ $28.08, valued at $210.6k
10/12/2021 4 Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.
Txns: Granted 42,191 options to buy @ $16, valued at $675.1k
10/07/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/09/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
04/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2020 4 Civik Thomas (President and CEO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.
Txns: Granted 75,000 shares @ $0
Granted 480,000 options to buy @ $2.72, valued at $1.3M
04/14/2020 3 Civik Thomas (President and CEO) has filed a Form 3 on FIVE PRIME THERAPEUTICS, INC.
08/02/2018 4 Civik Thomas (Chief Commercial Officer) has filed a Form 4 on Foundation Medicine, Inc.
Txns: Disposed of 33,421 shares @ $137, valued at $4.6M
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/20/2017 3 Civik Thomas (Chief Commercial Officer) has filed a Form 3 on Foundation Medicine, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy